查看購物車
  • Simplified Chinese
  • English
  • Japanese
HIV 護理點 (POC) 檢測市場：管道報告（發展階段、細分市場、地區/國家、監管途徑、主要參與者）
市場調查報告書
商品編碼
1398311

HIV 護理點 (POC) 檢測市場：管道報告（發展階段、細分市場、地區/國家、監管途徑、主要參與者）

HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
出版日期: | 出版商: GlobalData | 英文 109 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

HIV 護理點 (POC) 測試被定義為在患者接受治療的地方附近、臨床實驗室之外進行的醫學診斷測試。 POC 通常由臨床實驗室以外的人員執行，結果用於臨床決策。 POC 的複雜性和程序各不相同，從手動技術到自動分析儀。 POC 儀器通常是 "手持式" 的，並且可能是小型便攜式分析設備。

本報告檢視了 HIV 即時照護 (POC) 檢測市場，提供產品概述、正在開發的管道產品趨勢、不同開發階段產品的比較分析以及正在進行的臨床試驗的資訊。我們提供資訊關於參與公司的最新趨勢。

目錄

第 1 章目錄

第 2 章簡介

  • HIV 即時檢測 (POC) 檢測概述

第三章開發中的產品

  • HIV 即時護理 (POC) 檢測 - 按開發階段劃分的管道產品
  • HIV 護理點 (POC) 檢測 - 按地區劃分的在研產品
  • HIV 護理點 (POC) 檢測 - 按監管途徑劃分的管道產品
  • HIV 護理點 (POC) 檢測 - 管道產品（按預計批准日期）
  • HIV 護理點 (POC) 檢測 - 正在進行的臨床試驗

第 4 章 HIV 照護點 (POC) 檢測 - 公司正在開發的管道產品

  • HIV 護理點 (POC) 檢測公司 - 按開發階段劃分的管道產品
  • HIV 護理點 (POC) 測試 - 按開發階段劃分的管道產品

第五章 HIV 即時檢測 (POC) 檢測公司與產品概述

第 6 章 HIV 照護點 (POC) 檢測 - 最新進展

第七章附錄

  • 調查方法
  • 關於環球數據
  • 聯絡我們
  • 免責聲明

Abstract

GlobalData's Medical Devices sector report, "HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the HIV Point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

HIV Point of care (POC) Tests is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care. POC is typically performed by non-laboratory personnel and the results are used for clinical decision making. POC has a range of complexity and procedures that vary from manual methodologies to automated analyzers. POC devices are often 'handheld' or may be small portable analyzers.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the HIV Point of care (POC) Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of HIV Point of care (POC) Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of HIV Point of care (POC) Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 HIV Point of care (POC) Tests Overview

3 Products under Development

  • 3.1 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
  • 3.2 HIV Point of care (POC) Tests - Pipeline Products by Territory
  • 3.3 HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
  • 3.4 HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
  • 3.5 HIV Point of care (POC) Tests - Ongoing Clinical Trials

4 HIV Point of care (POC) Tests - Pipeline Products under Development by Companies

  • 4.1 HIV Point of care (POC) Tests Companies - Pipeline Products by Stage of Development
  • 4.2 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development

5 HIV Point of care (POC) Tests Companies and Product Overview

6 HIV Point of care (POC) Tests- Recent Developments

  • 6.1 Oct 10, 2023: Trinity Biotech Welcomes the Decision of the High Court of Kenya to Strike Out the Applications to Prevent the Procurement of Trinscreen HIV by the Kenyan Ministry of Health
  • 6.2 Sep 27, 2023: Update on MedMira's Regulatory Path in Canada and the USA
  • 6.3 Jun 14, 2023: Atomo and Newfoundland Sign Agreement for HIV Testing in Europe
  • 6.4 Mar 22, 2023: Trinity Biotech welcomes TrinScreen HIV's inclusion in the New Kenyan HIV Testing Algorithm
  • 6.5 Feb 28, 2023: Significant purchase order for HIV self-tests for Europe

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
  • HIV Point of care (POC) Tests - Pipeline Products by Territory
  • HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
  • HIV Point of care (POC) Tests - Pi

List of Figures

List of Figures

  • HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
  • HIV Point of care (POC) Tests - Pipeline Products by Territory
  • HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
  • HIV Point of care (POC) Tests - P